Category Patents/Designs/Trade Secrets

New Medical Technologies Bring New IP Challenges

LYON, FRANCE – At the cutting edge of medical technology lie new hopes for patients, but also serious ethical concerns and potential intellectual property snags. Read More...

Kenya Conference: Financial Incentives Needed For Tailored Neglected Disease Research

NAIROBI - Governments in Kenya and other developing nations must be willing to provide financial incentives if they expect companies to carry out research and development of drugs specifically tailored to those countries' needs, a conference in Nairobi was told last week.

New Thinking On Biotech Patents From Industry Groups

LYON, FRANCE - A new level of willingness to cooperate on major public health initiatives may indicate increased convergence in goals between large pharmaceutical companies and patient advocacy groups, particularly when addressing neglected diseases, a panel at an international life sciences conference said Monday.

World Health Organization Issues Statement On Generic Drug Seizures

The World Health Organization on Friday issued a statement on a high-profile debate over Dutch customs authorities’ delays of shipments of legitimate generic pharmaceuticals passing through the European country on their way to patients in developing countries. The goods were apparently believed to be counterfeit medicines.

Lamy Restarts Informal WTO Process On Proposals On IP And Biodiversity, GI Extension

World Trade Organization Director General Pascal Lamy on Wednesday kicked off informal talks on two key intellectual property issues that have been stalled by disagreements on the forum and mandate for their discussion.

WTO Review Finds Brazil Progressing On Trade Policy, IP Rights Protection

Brazil, once criticised for lax intellectual property rights protection, has been stepping up implementation and enforcement of international IP rules in recent years, a World Trade Organization body announced Wednesday. But some major rights-holding nations urged the government to undertake further work.

Administrative Patent Validity Determinations If The Proposed US Patent Reform Act Of 2009 Passes

On 3 March, 2009, bills were introduced in the US Congress setting forth the proposed "Patent Reform Act of 2009". The legislation proposes significant changes to post-issuance proceedings available to challenge patents in the United States. US attorneys Matthew A. Smith, Stephen B. Maebius and Jon W. Dudas argue the proposed legislation will be a step toward improving patent quality.

Alarm Escalates Over Delayed Generic Drug Shipments As Action Sought

Health advocates on Friday escalated their alarm over recent seizures by the Dutch government of shipments of legitimate generic pharmaceuticals passing through Europe on their way to developing countries. The European Commission has defended its actions as permissible under its own and international rules, but is being asked to look more carefully at those rules.

WHO Launches Online Hearing On Innovative Funding Sources For R&D

The World Health Organization is soliciting new ideas for funding sources to stimulate research and development on diseases predominantly afflicting developing countries, with some in developed countries. The web-based public hearing, being held online from 7 March to 15 April, will contribute to an intergovernmental mandate to come up with ways to address the shortage of research in this areas.